AIM
Advantage Investment Management’s Alaunos Therapeutics TCRT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $6K | Hold |
1,500
| – | – | ﹤0.01% | 746 |
|
2019
Q2 | $9K | Hold |
1,500
| – | – | 0.01% | 683 |
|
2019
Q1 | $6K | Hold |
1,500
| – | – | ﹤0.01% | 743 |
|
2018
Q4 | $3K | Buy |
+1,500
| New | +$3K | ﹤0.01% | 869 |
|
2018
Q2 | – | Sell |
-100
| Closed | – | – | 1030 |
|
2018
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 1060 |
|
2017
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 1070 |
|
2017
Q3 | $1K | Sell |
100
-100
| -50% | -$1K | ﹤0.01% | 1004 |
|
2017
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 1043 |
|
2017
Q1 | $1K | Sell |
200
-524
| -72% | -$2.62K | ﹤0.01% | 950 |
|
2016
Q4 | $4K | Buy |
724
+524
| +262% | +$2.9K | ﹤0.01% | 783 |
|
2016
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 886 |
|
2016
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 842 |
|
2016
Q1 | $1K | Sell |
200
-400
| -67% | -$2K | ﹤0.01% | 835 |
|
2015
Q4 | $5K | Buy |
600
+384
| +178% | +$3.2K | ﹤0.01% | 691 |
|
2015
Q3 | $2K | Buy |
216
+184
| +575% | +$1.7K | ﹤0.01% | 759 |
|
2015
Q2 | $0 | Sell |
32
-283
| -90% | – | ﹤0.01% | 910 |
|
2015
Q1 | $3K | Sell |
315
-185
| -37% | -$1.76K | ﹤0.01% | 752 |
|
2014
Q4 | $3K | Buy |
+500
| New | +$3K | ﹤0.01% | 676 |
|